Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05925075

Point of Care Lung Ultrasound in Preterm Infants with Respiratory Distress

Point of Care Lung Ultrasound in Preterm Infants with Respiratory Distress: a Multicenter Prospective Study

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Phoenix Children's Hospital · Academic / Other
Sex
All
Age
0 Days
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to learn about the role of bedside lung ultrasound in infants born prematurely with breathing problems. The main question this study aims to answer is: Can bedside lung ultrasound performed in the first month of life predict the development of chronic lung disease in premature infants?

Detailed description

This is a multicenter study including preterm infants born less than 32 weeks gestational age and with a diagnosis of respiratory distress syndrome (RDS). Our primary aim is to determine the ability of lung ultrasounds performed in the first month of life to predict the development of bronchopulmonary dysplasia (BPD) at 36 weeks postmenstrual age. Secondary aims will evaluate the association of lung ultrasound scores with the severity of hemodynamically significant patent ductus arteriosus (PDA) at time of diagnosis, as well as describe lung ultrasound changes pre and post-treatment with systemic steroid course. Hypothesis: 1. LUS scores would have a predictive ability to identify extreme preterm infants at risk of BPD with AUC\>0.8. 2. Higher LUS scores would correlate with higher severity of hemodynamically significant PDA. 3. LUS scores are expected to be lower after the course of systemic steroids and with lower scores are expected to predict successful extubation following the course of systemic steroids.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLung UltrasoundLung ultrasound to be performed at scheduled intervals as described in individual cohorts.

Timeline

Start date
2023-04-17
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2023-06-29
Last updated
2024-11-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05925075. Inclusion in this directory is not an endorsement.